Clinical Trial: A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult Volunteers

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784608) titled 'A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult Volunteers' on Aug. 05.

Brief Summary: This study aims to evaluate the pharmacokinetic interactions between HUC2-744-A and HUC2-744-B following monotherapy or co-administration under multiple-dose conditions.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Drug-drug Interactions

Intervention: DRUG: Atorvastatin Calcium

HUC2-744-A

DRUG: Telmisartan

HUC2-744-B

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Huons Co., Ltd.

Published by HT Digital Content Services with permission from...